Rethinking the INN system for therapeutic antibodies (Q41821601)

12 October 2017

Rethinking the INN system for therapeutic antibodies (English)

1 reference

12 October 2017

Jérémy Pottier

1 reference

12 October 2017

Romane Chastang

series ordinal

1 reference

12 October 2017

Christophe Dumet

series ordinal

1 reference

12 October 2017

Hervé Watier

series ordinal

1 reference

12 October 2017

language of work or name

1 reference

3 November 2016

1 reference

12 October 2017

Monoclonal Antibodies

1 reference

12 October 2017

1 reference

12 October 2017

1 reference

12 October 2017

5-11

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

12 October 2017

start time

3 November 2016

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

The INNs and outs of antibody nonproprietary names

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14.18K322A

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

IgG subclasses and allotypes: from structure to effector functions

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

MAbImprove: a French "Laboratoire d'excellence" (LabEx) dedicated to therapeutic antibodies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Genetic variants of IgG1 antibodies and FcγRIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Immunogenicity of therapeutic proteins: influence of aggregation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Human immunoglobulin allotypes: possible implications for immunogenicity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Structural and functional characterization of disulfide isoforms of the human IgG2 subclass

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Antibody humanization: a case of the 'Emperor's new clothes'?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

The covalent structure of an entire gammaG immunoglobulin molecule

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Localization of antibody-combining sites within the variable portions of heavy and light chains

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5240647

Prevention and management of obinutuzumab-associated toxicities: Australian experience

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27808597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

EXPERT committee on the unification of pharmacopoeias; report on the sixth session, New York City, N.Y. , 20-29 April 1950

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27808597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27808597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/19420862.2016.1255520

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

27808597

1 reference